G7 to Sustain Dexcom’s Lead in CGM; CMS will Boost Type 2 Use
Will Dexcom’s U.S. launch of its next-gen continuous glucose monitor drive meaningful market share shifts? How much penetration can it garner among Type 2 diabetics?
Report Date :
12/22/2022
Topic :
Dexcom Inc.
Source Silos :
1) Endocrinologists and their team members
2) Nurse educators
3) Diabetes device sales professionals
4) Industry specialists
Sector :
Health Care
Companies :
ABT, DXCM, MDT, SENS
Industry :
Health Care Equipment & Supplies
G7 to Sustain Dexcom’s Lead in CGM; CMS will Boost Type 2 Use PDF